MENU
ALEC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Alector (ALEC) Ownership - Who owns Alector?
Alector Inc is a clinical-stage biopharmaceutical company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
131 Oyster Point Boulevard
Phone
+1 415 231-5660
Employees
244
Web
https://www.alector.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
109.99M
P/E Ratio
N/A
Total Cash
413.4M
Projected Growth
N/A
Total Debt
42.52M
Revenue
100.56M
Risk (Beta)
0.26
Dividend Yield
N/A
Total Cash/Share
4.17
Total Debt/Equity
N/A
Revenue/Share
1.04 USD as % of share price
Fundamentals
ALEC
Capitalization
110M
P/E Ratio
N/A
Risk (Beta)
0.26
Dividend Yield
N/A
Total Cash
413M
Total Cash/Share
4.17
Total Debt
42.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.04%
Revenue
101M
ROE
N/A
Book Value
127M
P/B Ratio
0.87
Cash Flow
N/A
Earnings
-1.23
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
3.40
Current Revenue Per Employee
227899.16
Dividends Per Share - Security
N/A
EBITDA
-136.16M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-21.84
Shares Held By Institutions
224M
Shares Outstanding - Current
99.1M
Total Liabilities
342M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-37.566
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutics for Alzheimer's disease and other neurodegenerative disorders
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
131 Oyster Point Boulevard
Phone
+1 415 231-5660
Employees
244
Web
https://www.alector.com